 Toronto-based, Cybin Inc. NEO: CYBN NYSE: CYBN, a biopharmaceutical company focused on progressing Psychedelics to Therapeutics, reported its unaudited financial results on Monday for the second quarter ended September 30, 2021. Second-Quarter Financial Highlights 